Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-09

Clinical Trial Update: S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial update on celecoxib for preventing breast cancer in premenopausal women; study terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-04-09